Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea to treat proliferative disease

US Patent 7968543 · Granted Jun 28, 2011

Assignee

Inventors

View full patent text on Google Patents →